Page 245 - Quantitative Imaging of Small Tumours with Positron Emission Tomography

Addendum List of publications Cysouw MCF, Kramer GM, Hoekstra OS, et al. Accuracy and Precision of Partial- Volume Correction in Oncological PET/CT Studies. J Nucl Med. 2016;57(10):1642- 1649. Bouman-Wammes EW, van Dodewaard-de Jong, Dahele M, Cysouw MCF et al. Benefits of using stereotactic body radiotherapy in patients with metachronous oligometastases of hormone-sensitive prostate cancer detected by [18F]fluoromethylcholine PET/CT. Clin Genitourin Cancer. 2017;15(5):e773-e782. Cysouw MCF, Kramer GM, Frings V, et al. Baseline and longitudinal variability of normal tissue uptake values of [18F]-fluorothymidine-PET images. Nucl Med Biol. 2017;51:18-24. Cysouw MCF, Kramer GM, Schoonmade LJ, et al. Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2017;44(12):2105-2116. Cysouw MCF, Bouman-Wammes EW, Oprea-Lager DE, et al. Prognostic value of [18F]-fluoromethylcholine positron-emission tomography before stereotactic body radiotherapy for oligometastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):406-410. Jansen BHE, Kramer GM, Cysouw MCF, et al. Healthy Tissue Uptake of 68Ga-Prostate Specific Membrane Antigen (PSMA), 18F-DCFPyL, 18F-Fluoromethylcholine (FCH) and 18F-Dihydrotestosterone (FDHT). J Nucl Med. 2019 Jan 10. Cysouw MCF, Golla SVS, Frings V, et al. Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics. EJNMMI Res. 2019 Feb 4;9(1):12. Jansen BHE, Yaqub M, Voortman J, Cysouw MCF, et al. Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer. J Nucl Med. 2019 Apr 18. 244